PEG-ELS

PreclinicalSmall molecule

Ferring

PEG-ELS is one of 11 small molecule programs targeting Hyponatremia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HyponatremiaActive, not recruiting

HyponatremiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

21 competitors in Hyponatremia

#DrugCompanyPhaseTrials

Samsca

Otsuka

Approved

16 2

Jardiance

Boehringer Ingelheim

Approved

2 3

Vaprisol

CCumberland Pharmaceuticals

Phase 3

4 4

Sterile Urea

Pfizer

Phase 2

1 5

Lixivaptan

PPalladio Biosciences

Phase 3

3 6

Satavaptan

Sanofi

Phase 3

1 7

SR121463B

Sanofi

Phase 3

1 8

YM087

CCumberland Pharmaceuticals

Phase 3

2 9

Conivaptan Hydrochloride

CCumberland Pharmaceuticals

Phase 3

1 10

Proamatine

Takeda

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Bowel Preparation2 trials

Mizone vs Water for Bowel Preparation.

Completed·NNingbo No. 1 Hospital·N/A·NCT04247386·270 enrolled

A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy

Unknown status·SSouthern California Institute for Research and Education·N/A·NCT01028573·400 enrolled

Hyponatremia1 trial

Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS

Completed·TThomas Jefferson University·N/A·NCT01299779·460 enrolled

Safety and Efficacy1 trial

A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Completed·BBraintree Laboratories·Phase 3·NCT02819323·91 enrolled

Bowel Preparation for Colonoscopy1 trial

Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy

Completed· Ferring logo

Ferring·Phase 3·NCT01356407·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for PEG-ELS. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — PEG-ELS compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for PEG-ELS. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ferring company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Ferring

PEG-ELS

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Bowel Preparation2 trials

Hyponatremia1 trial

Safety and Efficacy1 trial

Bowel Preparation for Colonoscopy1 trial

References

Drug Info

Quick Facts

Related News